C0005847||Vascular
C0075233||Aldosterone Synthase
C1601799||Phosphate
C0243095||Osteogenic Transformation
C0005847||Vascular
C1135918||Smooth Muscle Cells
C0342649||Vascular calcification
C0085681||hyperphosphatemia
C1561643||chronic kidney disease
C1561643||chronic kidney disease
C0342649||Vascular calcification
C0002006||aldosterone
C0243095||osteogenic transformation
C0005847||vascular
C1135918||smooth muscle cells
C1135918||vascular smooth muscle cells
C0002006||aldosterone
C1148560||silencing
C1148560||pharmacological inhibition
C0037982||spironolactone
C0961485||eplerenone
C0066563||mineralocorticoid receptor
C0066563||mineralocorticoid receptor
C1601799||phosphate
C0243095||osteo-
C0243095||chondrogenic transformation
C0086418||human
C0003483||aortic
C1135918||smooth muscle cells
C1135918||human aortic smooth muscle cells
C1601799||phosphate
C0041904||up-regulated
C0075233||aldosterone synthase
C1527416||CYP11B2
C1171362||expression
C1135918||human aortic smooth muscle cells
C1148560||Silencing
C0033626||deficiency
C1527416||CYP11B2
C1135918||vascular smooth muscle cells
C1601799||phosphate
C1533591||calcification
C1601799||Phosphate
C0887840||nuclear export
C0140145||APEX1
C1413857||CYP11B2
C1336789||transcriptional repressor
C0140145||APEX1
C1148560||silencing
C0041904||up-regulated
C1413857||CYP11B2
C0017262||expression
C0243095||osteo-
C0243095||chondrogenic transformation
C0140145||APEX1
C1514559||overexpression
C1601799||phosphate
C0243095||osteo-
C0243095||chondrogenic transformation
C1533591||calcification
C1135918||human aortic smooth muscle cells
C1413857||Cyp11b2
C0017262||expression
C0003483||aortic
C0040300||tissue
C0085681||hyperphosphatemic
C0025929||klotho-hypomorphic (kl/kl) mice
C1883559||wild-type
C0025929||mice
C0025929||adrenalectomized kl/kl mice
C0037982||spironolactone
C0003483||aortic
C1135918||vascular smooth muscle cells
C0075233||aldosterone synthase
C0041904||up-regulated
C1601799||phosphate
C0140145||APEX1
C0038855||gene suppression
C0005847||Vascular
C1527416||CYP11B2
C1135918||vascular smooth muscle cells
C0243095||osteo-
C0243095||chondrogenic transformation
C0085681||hyperphosphatemia